DrugAlert provides timely advice direct to your inbox and is based on information from drug manufacturers regarding critical changes to medication access such as the discontinuation, short supply or unavailability, recalls and other important drug-related information. See below to view the most recent volumes of DrugAlert.
HPS Pharmacies wish to give notice that Bayer Australia, in consultation with the Therapeutic Goods Administration (TGA), has issued a product recall for Gastrografin® Oral Liquid and Urografin® Injection as follows: Product ARTG Affected…
Read more
HPS Pharmacies wish to advise that all brands of betahistine 16mg tablets are experiencing a supply interruption as follows: Product ARTG Estimated return date Betahistine Lupin 388870 Early March 2026 Betahistine Sandoz 253732 Late…
Read more
HPS Pharmacies wish to give notice that Sandoz, in consultation with the Therapeutic Goods Administration (TGA), has issued a product alert for Oxycodone Sandoz Modified Release Tablets as follows: Oxycodone Sandoz Modified Release Tablets…
Read more
HPS Pharmacies wish to give notice that Sanofi-Aventis is discontinuing Epilim® Crushable tablets as follows: Epilim® Crushable Tablets Sodium valproate 100mg ARTG 15373 Epilim® Crushable tablets are set to be deleted from the…
Read more
HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for Dantrium® vials as follows: Dantrium® Vials Dantrolene sodium hemiheptahydrate 20mg ARTG 14435 Normal supplies are expected to resume by the end…
Read more
Further to DrugAlert vol 1041, HPS Pharmacies wish to provide an update on the availability of Palexia® IR as follows: Palexia® IR 50mg Tablets Tapentadol (as hydrochloride) 50 mg ARTG 165310 The short-term supply…
Read more
